Medidata Solutions, Inc. (MDSO) Now Covered by Analysts at Dougherty & Co

Dougherty & Co started coverage on shares of Medidata Solutions, Inc. (NASDAQ:MDSO) in a research report released on Thursday, November 2nd, Marketbeat Ratings reports. The firm issued a neutral rating on the stock.

Several other research analysts also recently commented on the stock. Zacks Investment Research cut shares of Medidata Solutions from a hold rating to a sell rating in a research report on Friday, July 21st. Wells Fargo & Company decreased their target price on shares of Medidata Solutions from $83.00 to $80.00 and set a market perform rating on the stock in a research report on Friday, October 27th. J P Morgan Chase & Co upped their target price on shares of Medidata Solutions to $87.00 and gave the company an overweight rating in a research report on Tuesday, July 18th. SunTrust Banks, Inc. restated a buy rating and set a $92.00 target price on shares of Medidata Solutions in a research report on Friday, October 27th. Finally, Citigroup Inc. reissued a buy rating and issued a $95.00 price objective (up from $94.00) on shares of Medidata Solutions in a research report on Monday, July 24th. Five research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The stock has a consensus rating of Buy and an average target price of $83.54.

Shares of Medidata Solutions (NASDAQ:MDSO) opened at $69.89 on Thursday. Medidata Solutions has a 1 year low of $47.77 and a 1 year high of $85.92. The company has a debt-to-equity ratio of 0.61, a quick ratio of 3.37 and a current ratio of 1.29. The stock has a market cap of $4,010.00, a price-to-earnings ratio of 82.70, a PEG ratio of 4.43 and a beta of 1.77.

Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings data on Thursday, October 26th. The company reported $0.33 EPS for the quarter, beating the consensus estimate of $0.31 by $0.02. Medidata Solutions had a net margin of 7.84% and a return on equity of 11.54%. The business had revenue of $140.08 million during the quarter, compared to the consensus estimate of $141.27 million. During the same quarter in the prior year, the firm earned $0.28 EPS. The business’s revenue was up 16.7% on a year-over-year basis. sell-side analysts forecast that Medidata Solutions will post 0.77 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This story was first reported by BBNS and is the property of of BBNS. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this story can be read at https://baseballnewssource.com/markets/medidata-solutions-inc-mdso-receives-new-coverage-from-analysts-at-dougherty-co/1752118.html.

In other Medidata Solutions news, EVP Michael I. Otner sold 10,000 shares of the firm’s stock in a transaction on Thursday, November 2nd. The shares were sold at an average price of $70.88, for a total value of $708,800.00. Following the completion of the transaction, the executive vice president now owns 80,674 shares of the company’s stock, valued at $5,718,173.12. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Tarek Sherif sold 200,000 shares of the firm’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $68.76, for a total transaction of $13,752,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 225,944 shares of company stock worth $15,568,274. Insiders own 5.80% of the company’s stock.

Several institutional investors have recently modified their holdings of the stock. Alps Advisors Inc. raised its holdings in shares of Medidata Solutions by 0.3% during the second quarter. Alps Advisors Inc. now owns 8,430 shares of the company’s stock worth $659,000 after purchasing an additional 22 shares during the last quarter. 1st Global Advisors Inc. raised its holdings in shares of Medidata Solutions by 0.5% during the second quarter. 1st Global Advisors Inc. now owns 8,243 shares of the company’s stock worth $645,000 after purchasing an additional 37 shares during the last quarter. World Asset Management Inc raised its holdings in shares of Medidata Solutions by 1.2% during the second quarter. World Asset Management Inc now owns 3,528 shares of the company’s stock worth $276,000 after purchasing an additional 43 shares during the last quarter. State Board of Administration of Florida Retirement System raised its holdings in shares of Medidata Solutions by 0.3% during the second quarter. State Board of Administration of Florida Retirement System now owns 33,828 shares of the company’s stock worth $2,645,000 after purchasing an additional 109 shares during the last quarter. Finally, Pinebridge Investments L.P. raised its holdings in shares of Medidata Solutions by 2.1% during the second quarter. Pinebridge Investments L.P. now owns 7,305 shares of the company’s stock worth $572,000 after purchasing an additional 153 shares during the last quarter. 97.52% of the stock is owned by hedge funds and other institutional investors.

About Medidata Solutions

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Analyst Recommendations for Medidata Solutions (NASDAQ:MDSO)

Receive News & Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Toronto Blue Jays Launch Internal Investigation on PED Use
Toronto Blue Jays Launch Internal Investigation on PED Use
Seattle Mariners Start Offseason With a Bang: Three Trades Over Four Days
Seattle Mariners Start Offseason With a Bang: Three Trades Over Four Days
MLB Commissioner: New Rule for Pace-of-Play in 2018
MLB Commissioner: New Rule for Pace-of-Play in 2018
Alex Cobb Could Be Good Fit for Cubs
Alex Cobb Could Be Good Fit for Cubs
Joey Votto Is One of Baseball’s Best Hitters
Joey Votto Is One of Baseball’s Best Hitters
Hunter Pence May Become Part-Time Player
Hunter Pence May Become Part-Time Player


Leave a Reply

 
© 2006-2017 BBNS.